Sonoma Pharmaceuticals Inc (SNOA) — Long-term Investment Intensity
Sonoma Pharmaceuticals Inc (SNOA) has a Long-term Investment Intensity of 30.2% as of March 2015. Long-term investments of $4.54 Million represent 30.2% of total assets of $15.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check total reinvestment intensity of Sonoma Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sonoma Pharmaceuticals Inc Long-term Investment Intensity (2014–2015)
This chart shows how Sonoma Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2014 to 2015. As of March 2015, the intensity stands at 30.2%, reflecting long-term investments of $4.54 Million against total assets of $15.05 Million USD. Explore Sonoma Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Sonoma Pharmaceuticals Inc (2014–2015)
The table below presents the year-by-year Long-term Investment Intensity for Sonoma Pharmaceuticals Inc from 2014 to 2015, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sonoma Pharmaceuticals Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2015 | 30.2% | $4.54 Million | $15.05 Million | ▼ -18.7 pp |
| 2014 | 48.8% | $10.15 Million | $20.79 Million | — |